Effect of genotypic differences in CYP2C19 status on the cure rates for gastroesophageal reflux disease by lansoplazole

被引：0
|
作者：
Furuta, T [1 ]
Shirai, N [1 ]
Xiao, P [1 ]
Kajimura, M [1 ]
Hanai, H [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2203
引用
收藏
页码：A432 / A432
页数：1
相关论文
共 50 条
  • [31] A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences
    Ando, T
    Kato, H
    Sugimoto, N
    Nagao, Y
    Seto, N
    Hongo, H
    Kajikawa, H
    Isozaki, Y
    Shimozawa, M
    Naito, Y
    Yoshida, N
    Ishizaki, T
    Yoshikawa, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (09) : 1625 - 1631
  • [32] A Comparative Study on Endoscopic Ulcer Healing of Omeprazole Versus Rabeprazole with Respect to CYP2C19 Genotypic Differences
    Takashi Ando
    Haruki Kato
    Naohito Sugimoto
    Yasuyuki Nagao
    Nobuyuki Seto
    Hitoshi Hongo
    Hirokazu Kajikawa
    Yutaka Isozaki
    Makoto Shimozawa
    Yuji Naito
    Norimasa Yoshida
    Takashi Ishizaki
    Toshikazu Yoshikawa
    Digestive Diseases and Sciences, 2005, 50 : 1625 - 1631
  • [33] Effects of genetic differences in CYP2C19 status on cure rates of Helicobacter pylori infection by dual rabeprazole/amoxicillin therapy in comparison with dual omeprazole/amoxicillin therapy.
    Furuta, T
    Shirai, N
    Takashima, M
    Xiao, F
    Hanai, H
    Ohashi, K
    Ishizaki, T
    GASTROENTEROLOGY, 2000, 118 (04) : A495 - A495
  • [34] Gender Differences in Impact of CYP2C19 Polymorphism on Development of Coronary Artery Disease
    Hokimoto, Seiji
    Tabata, Noriaki
    Akasaka, Tomonori
    Arima, Yuichiro
    Kaikita, Koichi
    Morita, Kazunori
    Kumagae, Naoki
    Oniki, Kentaro
    Nakagawa, Kazuko
    Ogawa, Hisao
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 65 (02) : 148 - 152
  • [35] Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes
    Tu, J. -H.
    Hu, D. -L.
    Dai, L. -L.
    Sun, Y.
    Fan, L.
    Zhang, M.
    Tan, Z. -R.
    Chen, Y.
    Li, Z.
    Zhou, H. -H.
    XENOBIOTICA, 2010, 40 (06) : 393 - 399
  • [36] Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population
    Sviri, S
    Shpizen, S
    Leitersdorf, E
    Levy, M
    Caraco, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) : 275 - 282
  • [37] Gender Differences in Impact of CYP2C19 Polymorphism on Risk of Coronary Artery Disease
    Hokimoto, Seiji
    Akasaka, Tomonori
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2014, 130
  • [38] Inhibitory effect of oral contraceptives on CYP2C19 activity is not significant in carriers of the CYP2C19*17 allele
    Pedersen, Rasmus S.
    Noehr-Jensen, Lene
    Brosen, Kim
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 (10): : 683 - 688
  • [39] In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease
    Ohnishi, A
    Murakami, S
    Akizuki, S
    Mochizuki, J
    Echizen, H
    Takagi, I
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (11): : 1221 - 1229
  • [40] CYP2C19 genotype variability in patients with refractory gastroesophageal reflux after per-oral endoscopic myotomy (POEM)
    Perbtani, Yaseen B.
    Westerveld, Donevan R.
    Yang, Dennis J.
    Draganov, Peter, V
    ENDOSCOPY INTERNATIONAL OPEN, 2021, 09 (06) : E843 - E847
12345